You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Jak

Showing 1 - 25 of 686
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial (Baricitinib 4 MG, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Baricitinib 4 MG
  • Placebo
  • (no location specified)
Jul 27, 2023

JAK-i on RA B-lymphocytes Tolerance and Disease Resolution

Recruiting
  • Rheumatoid Arthritis
  • B lymphocyte profiling
  • Rome, Italy
    Division of Clinical Immunology, Fondazione Policlinico Universi
Feb 22, 2023

Kohlmeier Degos Disease With Neurologic Involvement Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Recruiting
  • Kohlmeier Degos Disease With Neurologic Involvement
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 23, 2023

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

JAK/STAT Pathway in Sarcoidosis Granuloma Cells

Recruiting
  • Sarcoidosis
  • JAK-STAT Pathway Deregulation
  • Blood sample
  • Bobigny, France
    Service de pneumologie Hôpital Avicenne
Oct 3, 2022

JAK Inhibition in Ulcerative Colitis

Not yet recruiting
  • Analyzing Immune Composition Changes Upon JAK Inhibitor Treatment of Ulcerative Colitis Patients
  • JAK inhibitor treatment
  • (no location specified)
Jul 11, 2022

Alopecia Areata Trial in Sohag (Janus Kinase 1 and 2)

Recruiting
  • Alopecia Areata
  • Janus Kinase 1 and 2
  • Sohag, Egypt
    Sohag University hospitals
May 12, 2023

Toxic Epidermal Necrolysis Trial in Fuzhou (Abrocitinib)

Recruiting
  • Toxic Epidermal Necrolysis
  • Fuzhou, Fujian, China
    Department of Dermatology, the First Affiliated Hospital of Fuji
Oct 31, 2023

Rheumatoid Arthritis Trial ("apigenin" and "glycyrrhizin", "glycyrrhizin" and "boswellic acid", "")

Not yet recruiting
  • Rheumatoid Arthritis
  • "apigenin" and "glycyrrhizin"
  • +2 more
  • (no location specified)
Mar 27, 2023

Synovial and Adipose Tissue Composition in Overweight/Obese

Active, not recruiting
  • Rheumatoid Arthritis
  • Assessment of synovial- and adipose tissue-derived inflammatory biomarkers
  • Rome, Italy
    Division of Rheumatology
Mar 2, 2023

Active Non-anterior Non-infectious Uveitis Trial (Baricitinib 4 MG)

Not yet recruiting
  • Active Non-anterior Non-infectious Uveitis
  • Baricitinib 4 MG
  • (no location specified)
Dec 7, 2022

Food Allergy Trial in New York (Abrocitinib)

Recruiting
  • Food Allergy
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jul 29, 2022

Acneiform Eruptions Trial in Shanghai (Cream containing JAK Inhibitor)

Recruiting
  • Acneiform Eruptions
  • Cream containing JAK Inhibitor
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Jun 20, 2022

Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Abrocitinib 200 MG Oral Tablet
  • +2 more
  • (no location specified)
Feb 21, 2023

Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood

Not yet recruiting
  • Severe Aplastic Anemia
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 23, 2023

Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in

Not yet recruiting
  • Rheumatoid Arthritis
  • Observation
  • (no location specified)
Oct 8, 2022

Carotid Plaque Burden in Philadelphia Negative

Recruiting
  • Myeloproliferative Neoplasm
    • Sohag, Egypt
      Faculty of Medicine
    Aug 14, 2023

    JAK-STAT Signaling Pathway in Pyoderma Gangrenosum

    Not yet recruiting
    • Pyoderma Gangrenosum
    • +2 more
    • immunohistochemical methods
    • (no location specified)
    Mar 21, 2022

    Abatacept, Treatment Compliance, Rheumatoid Arthritis Trial in Hangzhou (Janus Kinase Inhibitor, Abatacept)

    Recruiting
    • Abatacept
    • +2 more
    • Hangzhou, Zhejiang, China
      Zhejiang Provincial People's Hospital
    Jul 5, 2022

    Cicatricial Alopecia Trial in New York (PF-06700841, Placebo)

    Recruiting
    • Cicatricial Alopecia
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Aug 16, 2022

    BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of

    Recruiting
    • BCR-JAK2 Fusion Protein Expression
    • +11 more
    • Palo Alto, California
    • +3 more
    Oct 5, 2022

    Chronic Hand Dermatitis Trial in Rochester (Ruxolitinib)

    Recruiting
    • Chronic Hand Dermatitis
    • Rochester, New York
      UR Medicine Dermatology College Town
    Aug 9, 2022

    Myelofibrosis Trial in Paris (Ruxolotinib)

    Completed
    • Myelofibrosis
    • Paris, France
      ROBIN
    Jul 26, 2022

    Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)

    Active, not recruiting
    • Chronic Graft vs Host Disease
    • Chronic Graft-Versus-Host Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 29, 2022

    Idiopathic Inflammatory Myopathies Trial in London (Baricitinib)

    Recruiting
    • Idiopathic Inflammatory Myopathies
    • London, United Kingdom
      King's College Hospital NHS Foundation Trust
    May 19, 2022